Bladder Cancer Gene Expression Analysis

[Up] [Top]

Documentation for package ‘curatedBladderData’ version 0.99.2

Help Pages

curatedBladderData Clinically Annotated Data for the Bladder Cancer Transcriptome
GSE13507_eset Predictive value of progression-related gene classifier in primary non-muscle invasive bladder cancer.
GSE1827_eset Bladder cancer outcome and subtype classification by gene expression.
GSE19915.GPL3883_eset Combined gene expression and genomic profiling define two intrinsic molecular subtypes of urothelial carcinoma and gene signatures for molecular grading and outcome.
GSE19915.GPL5186_eset Combined gene expression and genomic profiling define two intrinsic molecular subtypes of urothelial carcinoma and gene signatures for molecular grading and outcome.
GSE31189_eset A candidate molecular biomarker panel for the detection of bladder cancer.
GSE31684_eset Combination of a novel gene expression signature with a clinical nomogram improves the prediction of survival in high-risk bladder cancer.
GSE32894_eset A molecular taxonomy for urothelial carcinoma.
GSE37317_eset Transcriptional signatures of Ral GTPase are associated with aggressive clinicopathologic characteristics in human cancer.
GSE5287_eset Emmprin and survivin predict response and survival following cisplatin-containing chemotherapy in patients with advanced bladder cancer.
GSE89_eset Identifying distinct classes of bladder carcinoma using microarrays.
PMID17099711.GPL8300_eset Regional copy number-independent deregulation of transcription in cancer.
PMID17099711.GPL91_eset Regional copy number-independent deregulation of transcription in cancer.